TwinStrand Biosciences

TwinStrand Biosciences is a Seattle-based genomics company founded in 2015, focusing on Duplex Sequencing technology. This innovative approach detects ultra-low frequency genomic variants that traditional methods cannot identify, significantly reducing sequencing error rates. The company aims to enhance human health and accelerate scientific discovery through its proprietary technology, which is supported by over 100 patents and applications.

TwinStrand offers a range of products, including off-the-shelf DNA library preparation kits for Duplex Sequencing and an end-to-end solution that encompasses library preparation, sequencing, and bioinformatics applications. Their technology is applicable in various fields, such as healthcare for liquid biopsy diagnostics and cancer detection, as well as in life sciences for monitoring cellular immunotherapy and genetic toxicology. The company collaborates with pharmaceutical firms, academic institutions, and regulatory agencies to advance its mission and support diverse research needs.